Greenwich LifeSciences Inc.
GLSI | NASDAQ
$14.65
-$1.70 (-10.40%)
At close: Nov 5, 2026, 4:00 PM ET
$15.23
+$0.58 (+3.96%)
After-hours:
Nov 5, 2026, 5:04 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.78K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K |
Gross Profit | -1.78K | -3.61K | -3.61K | -3.61K | -3.61K | -3.61K |
Operating Income | -19.45M | -17.64M | -9.33M | -8.04M | -4.6M | -1.86M |
Interest Income | 89.7K | 223.01K | 436.06K | 215.02K | 27.37K | 832 |
Pretax Income | -19.36M | -17.41M | -8.89M | -7.83M | -4.57M | -1.86M |
Net Income | -19.36M | -17.41M | -8.89M | -7.83M | -4.57M | -1.86M |
Selling & General & Admin | 2.23M | 2.15M | 1.63M | 1.56M | 1.04M | 806.19K |
Research & Development | 17.22M | 15.48M | 7.7M | 6.48M | 3.56M | 1.06M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 19.45M | 17.63M | 9.32M | 8.04M | 4.59M | 1.86M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.45M | 17.64M | 9.33M | 8.04M | 4.6M | 1.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 13.53M | 13.01M | 12.85M | 12.91M | 12.94M | 12.7M |
Shares Outstanding (Diluted) | 13.53M | 13.01M | 12.85M | 12.91M | 12.94M | 12.7M |
EPS (Basic) | -1.43 | -1.21 | -0.69 | -0.61 | -0.35 | -0.15 |
EPS (Diluted) | -1.43 | -1.21 | -0.69 | -0.61 | -0.35 | -0.15 |
EBITDA | -19.36M | -17.41M | -8.89M | -7.82M | -4.57M | -1.86M |
EBIT | -19.36M | -17.41M | -8.89M | -7.83M | -4.57M | -1.86M |
Depreciation & Amortization | 1.78K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K |
Add to Watchlist
Select watchlists to add or remove GLSI